康泰医学收盘下跌1.90%，最新市净率2.70，总市值49.86亿元

Group 1 - The core business of Kangtai Medical is the research, production, and sales of medical diagnostic and monitoring equipment, covering various categories such as blood oxygen, electrocardiogram, ultrasound, monitoring, and blood pressure [1] - As of the first quarter of 2025, Kangtai Medical reported a revenue of 112 million yuan, representing a year-on-year increase of 12.77%, and a net profit of 16.44 million yuan, with a significant year-on-year increase of 277.67% [1] - The company achieved a gross profit margin of 58.15% in its latest earnings report [1] Group 2 - Kangtai Medical's stock closed at 12.41 yuan, down 1.90%, with a latest price-to-book ratio of 2.70 and a total market capitalization of 4.986 billion yuan [1] - The company has three institutional holders, including two funds and one other entity, with a total holding of 3.3463 million shares valued at 4.6 million yuan [1] - In April 2023, Kangtai Medical's Remoltar remote professional color Doppler ultrasound diagnostic system won the German IF Design Award and the Italian A Design Award [1]